The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_005343.3(HRAS):c.412G>A (p.Gly138Ser)

CA135988

45304 (ClinVar)

Gene: HRAS
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: 7b1915f1-7c70-4f7b-afa5-d08962f3c012
Approved on: 2019-07-25
Published on: 2019-07-26

HGVS expressions

NM_005343.3:c.412G>A
NM_005343.3(HRAS):c.412G>A (p.Gly138Ser)
NC_000011.10:g.533491C>T
CM000673.2:g.533491C>T
NC_000011.9:g.533491C>T
CM000673.1:g.533491C>T
NC_000011.8:g.523491C>T
NG_007666.1:g.7060G>A
ENST00000397594.7:c.412G>A
ENST00000417302.7:c.412G>A
ENST00000397594.6:c.130G>A
ENST00000417302.6:c.412G>A
ENST00000462734.2:c.412G>A
ENST00000311189.8:c.412G>A
ENST00000311189.7:c.412G>A
ENST00000397594.5:c.412G>A
ENST00000397596.6:c.412G>A
ENST00000417302.5:c.412G>A
ENST00000451590.5:c.412G>A
ENST00000462734.1:n.105G>A
ENST00000478324.5:n.122G>A
ENST00000479482.1:n.333G>A
ENST00000493230.5:c.412G>A
NM_001130442.1:c.412G>A
NM_005343.2:c.412G>A
NM_176795.3:c.412G>A
NM_001130442.2:c.412G>A
NM_001318054.1:c.93G>A
NM_176795.4:c.412G>A
NM_005343.4:c.412G>A
NM_001318054.2:c.93G>A
NM_001130442.3:c.412G>A
NM_176795.5:c.412G>A
More

Uncertain Significance

Met criteria codes 1
PP2
Not Met criteria codes 2
PS4 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The c.412G>A (p.Gly138Ser) variant in the HRAS gene has been identified in 1 Asian woman with Noonan Syndrome and 1 Asian man with Costello Syndrome (Laboratory for Molecular Medicine internal data). It has been also identified in 1 patient who had a combined cardiac panel (GeneDx internal data) and was observed in 3 unrelated women with breast cancer and 1 woman with uterine cancer (Invitae internal data). PS4_Supporting not met due to conflicting phenotypes between the identified patients. HRAS has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic missense variants are common (PP2; PMID: 29493581). In summary, the clinical significance of the p.Gly138Ser variant is uncertain. RASopathy-specific ACMG/AMP criteria applied (PMID:29493581): PP2.
Met criteria codes
PP2
HRAS is a missense constrained gene
Not Met criteria codes
PS4
Variant identified in 1 Asian woman with Noonan Syndrome and 1 Asian man with Costello Syndrome. Also identified in 1 patient in 2017 who had a combined cardiac panel (GeneDx internal data). Observed in 3 unrelated women with breast cancer and 1 woman with uterine cancer (Invitae internal data). PS4_Supporting not met due to conflicting phenotypes.
PM2
Present in .0000193% CI 95% (2/18390) East Asian alleles in gnomAD
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.